Trade DSGN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Design Therapeutics, Inc. (DSGN) is trading at US$13.01, up 3.63% today as of Sep 22, 12:37 EDT. The company has a market capitalisation of US$938.1M. Over the past 52 weeks, DSGN has traded between US$5.28 and US$17.25. On Syfe you can trade DSGN with $0 commission and add it to your watchlist.
| Previous close | US$12.55 |
|---|---|
| Market cap | US$938.1M |
| 52-week range | US$5.28 – US$17.25 |
| Volume | 505.77K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Design Therapeutics, Inc.
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.
Year: 2021
Design Therapeutics Q2 Net Loss Narrows
Aug 3, 12:43 PM · MT Newswires
Design Therapeutics' DT-216P2 Shows Clinical Improvements in Friedreich Ataxia Trial; Shares Rise Pre-Bell
May 18, 11:53 AM · MT Newswires
Cantor Fitzgerald Initiates Design Therapeutics at Overweight
May 12, 11:29 AM · MT Newswires
Oppenheimer Raises Price Target on Design Therapeutics to $21 From $18, Keeps Outperform Rating
May 4, 1:21 PM · MT Newswires
Design Therapeutics, Inc. (DSGN) stock is trading at US$13.01, +3.63% from the previous close of US$12.55.
The market cap for Design Therapeutics, Inc. (DSGN) stock is approximately US$938.1M.
The 52-week high for Design Therapeutics, Inc. (DSGN) stock is US$17.25.
The 52-week low for Design Therapeutics, Inc. (DSGN) stock is US$5.28.
Design Therapeutics, Inc. (DSGN) does not currently pay a dividend.
Stay on top of DSGN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
